- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | NEXGEL, INC.: NEXGEL Announces Date for Investor Update Call | 1 | GlobeNewswire (USA) | ||
| 20.08. | NEXGEL appoints Brian Kieser as interim CEO after Adam Levy steps down | 1 | Seeking Alpha | ||
| 20.08. | NEXGEL, INC. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 19.08. | NEXGEL Recalls SilverSeal From Amazon To Launch Product Into Higher-Margin Hospital Market | 5 | pulse2.com | ||
| 17.08. | NEXGEL reports Q2 results | 2 | Seeking Alpha | ||
| 17.08. | NEXGEL, INC. - 8-K, Current Report | 6 | SEC Filings | ||
| 29.07. | NEXGEL, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 02.07. | NEXGEL, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| NEXGEL Aktie jetzt für 0€ handeln | |||||
| 17.06. | NEXGEL, INC. - 8-K, Current Report | 4 | SEC Filings | ||
| 19.05. | Nexgel hydrogel patch reduces laser plume in hair removal study | 8 | Investing.com | ||
| 19.05. | NEXGEL, INC.: NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration | 1 | GlobeNewswire (USA) | ||
| 15.05. | Earnings Call zu Q1 2026: Nexgel meldet Umsatzrückgang, Aktie gibt nach | 2 | Investing.com Deutsch | ||
| 15.05. | NexGel Q1 2026 Earnings Call Transcript | 2 | Benzinga.com | ||
| 15.05. | NEXGEL GAAP EPS of -$0.11 misses by $0.04, revenue of $2.65M misses by $1.26M | 1 | Seeking Alpha | ||
| 14.05. | NEXGEL, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.05. | NEXGEL, INC.: NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical | 1 | GlobeNewswire (USA) | ||
| 12.05. | NEXGEL, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | NEXGEL, INC.: NEXGEL To Report First Quarter 2026 Financial Results on May 15th | 2 | GlobeNewswire (USA) | ||
| 06.05. | NEXGEL, INC.: NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience, to Board of Directors | 2 | GlobeNewswire (USA) | ||
| 30.04. | NEXGEL, INC. - 10-K/A, Annual Report | 1 | SEC Filings |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,460 | -0,36 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| BICO GROUP | 1,962 | -0,30 % | BICO Group AB: Publication of BICO Group AB: Interim Report Q2 2026 | Improved profitability and AI advancements
"In the quarter we had a continued solid momentum with growth in our bench top instruments and consumables businesses, while still experiencing challenges... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,068 | +5,26 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | XFRA 79O: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNUGEN MEDICAL DEV.... ► Artikel lesen | |
| CERENOME | 1,744 | -0,57 % | Cerenome, Inc.: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division | HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announces the appointment of Samantha... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,060 | +5,10 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report | ||
| SPINEWAY | 0,113 | 0,00 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,660 | +1,41 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Announces 2026 Interim Results | Corporate Health Management Business Grows Steadily; AI Healthcare Empowerment Drives Continued Profitability ImprovementHONG KONG, Aug. 19, 2026 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | +1,36 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,970 | +2,57 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 9,076 | -1,99 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,395 | -0,62 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| LIFEWARD | 7,030 | -1,82 % | Lifeward legt Termin für jährliche und außerordentliche Hauptversammlung 2026 fest | ||
| VIROMED MEDICAL | 5,550 | -1,77 % | EQS-DD: Viromed Medical AG: Heike Perbandt, Verkauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
14.09.2026 / 18:05... ► Artikel lesen |
NEXGEL INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,267 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXGEL INC finden Sie auf Wallstreet Online.